Board of Directors has approved the Industrial Plan 2025 – 2029.
The plan is structured around four strategic pillars:
- Strengthening the Software capabilities and reinforcing Gpi’s strategic position in Italy.
- Venturing into international markets, by prioritizing the vertical software offerings through the acquisitions of Tesi and Evolucare and focusing on transfusion information systems (Blood).
- Organizational transformation, towards a more integrated and efficient model.
- Business diversification into strategic areas adjacent to Software (Care, Automation).
As Fausto Manzana, CEO of the Group, comments:
“Over the last few years, we have expanded significantly investing in the future, allowing us to become a solid Group that has secured leadership in Italy’s digital health market, while making substantial international advancements. We’ve crafted a new Industrial Plan to outline the strategies that will guide us successfully in the future and detail our execution approach. Our identity as a company remains steadfast: our aim is to provide solutions that enhance care quality while creating value for our customers, shareholders, employees, and the broader community. Our product strategy is progressing by exploring innovative technologies and focusing on profitability. I am proud of our achievements to date and optimistic about the future we’re building. I am confident on a team which has shown unwavering dedication over the years, and with new recruits, it will be even more formidable in tackling future challenges.”
